Analysed ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) News Sources
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003
02-06-2026
yahoo.com
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
29-06-2026
yahoo.com
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
28-07-2026
yahoo.com
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
14-08-2026
yahoo.com
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors
28-04-2026
yahoo.com
Enveric Biosciences Announces Participation in 2026 BIO International Convention
16-06-2026
yahoo.com
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
05-08-2026
yahoo.com
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
01-09-2026
yahoo.com
What is the current price of ENVERIC BIOSCIENCES INC (ENVB:NASDAQ)?
The current price of ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) is $1.46.
ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) since the previous trading day is $-0.02.
ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) since the previous trading day is -1.3514%.
What is the most recent average sentiment score for ENVERIC BIOSCIENCES INC (ENVB:NASDAQ)?
The most recent average sentiment score for ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for ENVERIC BIOSCIENCES INC (ENVB:NASDAQ)?
The most recent sentiment for ENVERIC BIOSCIENCES INC (ENVB:NASDAQ) is .
SEC-8K** Filing Available For ENVERIC BIOSCIENCES INC (ENVB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.